Clinical and biological characteristics of adult de novo and secondary acute myeloid leukemia with balanced 11q23 chromosomal anomaly or MLL gene rearrangement compared to cases with unbalanced 11q23 anomaly: Confirmation of the existence of different entities with 11q23 breakpoint

Leukemia

Volumn 12, Issue 1, 1998, Pages 25-33

  Archimbaud, E ^a   Charrin, C ^b   Magaud, J P ^a,b   Campos, L ^c   Thomas, X ^a   Fiere D ^a   Rimokh, R ^a  

^a EDOUARD HERRIOT HOSPITAL   (France)

^b CENTRE LÉON BÉRARD   (France)

^c HÔPITAL NORD   (France)

Author keywords

11q23 breakpoint; Acute myeloid leukemia; Cytogenetics; MLL gene; Prognosis

Indexed keywords

ACUTE GRANULOCYTIC LEUKEMIA; ARTICLE; CHROMOSOME 11Q; CHROMOSOME ABERRATION; CHROMOSOME BREAKAGE; CHROMOSOME INVERSION; CHROMOSOME TRANSLOCATION; CLINICAL ARTICLE; GENE REARRANGEMENT; HUMAN; LEUKOCYTE COUNT; PRIORITY JOURNAL; PROGNOSIS; SOUTHERN BLOTTING; SPLENOMEGALY;

EID: 0031983604     PISSN: 08876924     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.leu.2400853     Document Type: Article

References (53)

1. Van den Berghe H, David G, Broeckaert-Van Orshoven A, Louwagie A, Verwilghen R, Casteels-VanDaele M, Eggermont E, Eeckels R. A new chromosome anomaly in acute lymphoblastic leukemia (ALL). Hum Genet 1979; 46: 173-180.
2. Parkin JL, Arthur DC, Abramson CS, McKenna RW, Kersey JH, Heideman RL, Brunning RD. Acute leukemia associated with the t(4;11) chromosome rearrangement: ultrastructural and immunologic characteristics. Blood 1982; 60: 1321-1331.
3. Kaneko Y, Maseki N, Takasaki N, Sakurai M, Hayashi Y, Nakazawa S, Mori T, Sakurai M, Takeda T, Shikano T, Hiyoshi Y. Clinical and hematologic characteristics in acute leukemia with 11q23 translocations. Blood 1986; 67: 484-491.
4. The Fourth International Workshop on Chromosomes in Leukemia. A prospective study of acute nonlymphocytic leukemia. Cancer Genet Cytogenet 1984; 11: 249-350.
5. Bernard OA, Berger R. Molecular basis of 11q23 rearrangements in hematopoietic malignant proliferations. Genes Chromosom Cancer 1995; 13: 75-85.
6. Hernandez JM, Mecucci C, Beverloo HB, Selleri L, Wlodarska I, Stul M, Michaux L, Verhoef G, Van Orshoven A, Cassiman JJ, Evans GA, Hagemeijer A, Van den Berghe H. Translocation (11;15)(q23;q14) in three patients with acute non-lymphoblastic leukemia (ANLL): clinical, cytogenetic and molecular studies. Leukemia 1995; 9: 1162-1166.
7. Cortes J, O'Brien S, Kantarjian H, Cork A, Stass S, Freireich E), Keating M, Pierce S, Estey E. Abnormalities in the long arm of chromosome 11(11q) in patients with de novo and secondary acute myelogenous leukemias and myelodysplastic syndromes. Leukemia 1995; 8: 2174-2178.
8. Pui CH, Raimondi S, Murphy SB, Ribeiro RC, Kalwinsky DK, Dahl GV, Crist WM, Williams DL. An analysis of leukemic cell chromosomal features in infants. Blood 1987; 69: 1289-1293.
9. Kaneko Y, Shikano T, Maseki N, Sakurai M, Sakurai M, Takeda T, Hiyoshi Y, Mimaya JI, Fujimoto T. Clinical characteristics of infant acute leukemia with or without 11q23 translocations. Leukemia 1988; 2: 672-676.
10. Raimondi SC, Peiper SC, Kitchingman GR, Behm FG, Williams DL, Hancock ML, Mirro J Jr. Childhood acute leukemia with chromosomal breakpoints at 11 q23. Blood 1989; 73: 1627-1634.
11. Archimbaud E, Charrin C, Guyotat D, Magaud JP, Gentilhomme O, Fière D. Acute leukemia with t(4;11) in patients previously exposed to carcinogens. Br J Haematol 1988; 69: 467-470.
12. Pedersen-Bjergaard J, Philip P, Olesen Larsen S, Jensen G, Byrsting K. Chromosome aberrations and prognostic factors in therapy-related myelodysplasia and acute nonlymphocytic leukemia. Blood 1990; 76: 1083-1091.
13. Sandoval C, Head DR, Mirro J Jr, Behm FG, Ayers GD, Raimondi SC. Translocation t(9;11)(p21 ;q23) in pediatric de novo and secondary acute myeloblastic leukemia. Leukemia 1992; 6: 513-519.
14. Rubin CM, Arthur DC, Woods WG, Lange BJ, Nowell PC, Rowley JD, Nachman J, Bostrom B, Baum ES, Suarez CR, Shah NR, Morgan E, Maurer HS, McKenzie SE, Larson RA, Le Beau MM. Therapy-related myelodysplastic syndrome and acute myeloid leukemia in children: correlation between chromosomal abnormalities and prior therapy. Blood 1991; 11: 2982-2988.
15. Pui CH, Ribeiro RC, Hancock ML, Rivera GK, Evans WE, Raimondi SC, Head DR, Behm FG, Mahmoud MH, Sandlund JT, Crist WM. Acute myeloid leukemia in children treated with epipodophyllotoxins for acute lymphoblastic leukemia. New Engl J Med 1991; 325: 1682-1687.
16. Pedersen-Bjergaard J, Sigsgaard TC, Nielsen D, Gjedde BS, Philip P, Hansen M, Olesen Larsen S, Rorth M, Mouridsen H, Dombernowsky P. Acute monocytic or myelomonocytic leukemia with balanced chromosome translocations to band 11q23 after therapy with 4-epi-doxorubicin and cisplatin or cyclophosphamide for breast cancer. J Clin Oncol 1992; 10: 1444-1451.
17. Gill Super HJ, McCabe NR, Thirman MJ, Larson RA, Le Beau MM, Pedersen-Bjergaard J, Philip P, Diaz MO, Rowley JD. Rearrangements of the MLL gene in therapy-related acute myeloid leukemia in patients previously treated with agents targeting DNA-topoisomerase II. Blood 1993; 82: 3705-3711.
18. Cimino G, Moir DT, Canaani O, Williams K, Crist WM, Katzav S, Cannizzaro L, Lange B, Nowell PC, Croce CM, Canaani E. Cloning of ALL-1, the locus involved in leukemias with the t(4;11)(q21 ;q23), t(9;11)(p22;q23), and t(11;19)(q23;p13) chromosome translocations. Cancer Res 1991; 51: 671 2-6714.
19. Tkachuk DC, Kohler S, Cleary ML. Involvement of a homolog of drosophila trithorax by 11q23 chromosomal translocations in acute leukemias. Cell 1992; 71: 691-700.
20. McCabe NR, Burnett RC, Gill HJ, Thirman MJ, Mbangkollo D, Kipiniak M, van Mellc E, Ziemm-van der Poel S, Rowley JD, Diaz MO. Cloning of cDNAs of the MLL gene that detect DNA rearrangements and altered RNA transcripts in human leukemic cells with 11q23 translocations. Proc Natl Acad Sci USA 1992; 89: 11794-11798.
21. Thirman MJ, Gill HJ, Burnett RC, Mbangkollo D, McCabe NR, Kobayashi H, Ziemin-van der Poel S, Kaneko Y, Morgan R, Sandberg AA, Chaganti RSK, Larson RA, Le Beau MM, Diaz MO, Rowley JD. Rearrangement of the MLL gene in acute lymphoblastic and acute myeloid leukemias with 11q23 chromosomal translocations. New Engl J Med 1993; 329: 909-914.
22. Cimino G, Lo Coco F, Biondi A, Elia L, Luciano A, Croce CM, Masera G, Mandelli F, Canaani E. ALL-1 gene at chromosome 11q23 is consistently altered in acute leukemia of early infancy. Blood 1993; 82: 544-546.
23. Yamamoto K, Seto M, Akao Y, lida S, Nekazawa S, Oshimura M, Takahashi T, Ueda R. Gene rearrangement and truncated mRNA in cell lines with 11q23 translocation. Oncogene 1993; 8: 479-485.
24. Kearney L, Bower M, Gibbons B, Das S, Chaplin T, Nacheva E, Chessells JM, Reeves, B, Riley JH, Lister TA, Young BD. Chromosome 11q23 translocations in both infant and adult leukemias are detected by in situ hybridization with a yeast artificial chromosome. Blood 1992; 80: 1659-1665.
25. Kobayashi H, Espinosa III R, Thirman MJ, Gill HJ, Fernald AA, Diaz MO, Le Beau MM, Rowley JD. Heterogeneity of breakpoints of 11q23 rearrangements in hematologic malignancies identified with fluorescence in situ hybridization. Blood 1993; 82: 547-551.
26. Samuels BL, Larson RA, Le Beau MM, Daly KM, Bitter M, Vardiman JW, Barker CM, Rowley JD, Colomb HM. Specific chromosomal abnormalities in acute nonlymphocytic leukemia correlate with drug susceptibility in vivo. Leukemia 1988; 2: 79-83.
27. Fenaux P, Preudhomme C, Lai JL, Morel P, Beuscart R, Bauters F. Cytogenetics and their prognostic significance in acute myeloid leukaemia: a report on 283 cases. BrJ Haematol 1989; 73: 61-67.
28. Berger R, Bernheim A, Ochoa-Noguera ME, Daniel MT, Valensi F, Sigaux F, Flandrin, G, Boiron M. Prognostic significance of chromosomal abnormalities in acute nonlymphocytic leukemia: a study of 343 patients. Cancer Genet Cytogenet 1987; 28: 293-299.
29. Bower M, Parry P, Carter M, Lillington DM, Amess J, Lister TA, Evans G, Young BD. Prevalence and clinical correlations of MLL gene rearrangements in AML-M4/M5. Blood 1994; 84: 3776-3780.
30. Cimino G, Rapanotti MC, Elia L, Biondi A, Fizzotti M, Testi AM, Tosti S, Croce CM, Canaani E, Mandelli F, Lo Coco F. ALL-1 gene rearrangements in acute myeloid leukemia: association with M4-M5 French-American-British classification subtypes and young age. Cancer Res 1995; 55: 1625-1628.
31. Keating MJ, Cork A, Broach Y, Smith T, Walters RS, McCredie KB, Trujillo J, Freireich EJ. Toward a clinically relevant cytogenetic classification of acute myelogenous leukemia. Leukemia Res 1987; 11: 119-133.
32. Keating MJ, Smith TL, Kantarjian H, Cork A, Walters R, Trujillo JM, McCredie KB, Gehan EA, Freireich EJ. Cytogenetic pattern in acute myelogenous leukemia: a major reproducible determinant of outcome. Leukemia 1988; 2: 403-412.
33. Arthur DC, Berger R, Golomb HM, Swansbury GJ, Reeves BR, Alimena G, Van Den Berghe H, Bloomfield CD, de la Chapelle A, Dewald GW, Carson OM, Hagemeijer A, Kaneko Y, Mitelman F, Pierre RV, Ruutu T, Sakurai M, Lawler SD, Rowley JD. The clinical significance of karyotype in acute myelogenous leukemia. Cancer Genet Cytogenet 1989; 40: 203-21 6.
34. Kalwinsky DK, Raimondi SC, Schell MJ, Mirro J Jr, Santana VM, Behm F, Dahl GV, Williams D. Prognostic importance of cytogenetic subgroups in de novo pediatric acute nonlymphocytic leukemia. J Clin Oncol 1990; 8: 75-83.
35. Marosi C, Koller U, Koller-Weber E, Schwarzinger I, Schneider B, Jäger U, Vahls P, Nowotny H, Pirc-Danoewinata H, Steger G, Kreiner G, Wagner B, Lechner K, Lutz D, Bettelheim P, Haas OA. Prognostic impact of karyotype and immunologic phenotype in 125 adult patients with de novo AML. Cancer Genet Cytogenet 1992; 61: 14-25.
36. Huret JL, Brizard A, Slater R, Charrin C, Bertheas MF, Guilhot F, Hahlen K, Kroes W, van Leeuwen E, Schoot EVD, Beishuizen A, Tanzer J, Hagemeijer A. Cytogenetic heterogeneity in t(11;19) acute leukemia: clinical, hematological and cytogenetic analyses of 48 patients - updated published cases and 16 new observations. Leukemia 1993; 7: 152-160.
37. Lo Coco F, Mandelli F, Breccia M, Annino L, Guglielmi C, Petti M, Testi AM, Alimena G, Croce CM, Canaani E, Cimino G. Southern blot analysis of ALL-1 rearrangements at chromosome 11q23 in acute leukemia. Cancer Res 1993; 53: 3800-3803.
38. Bennett JM, Catovsky D, Daniel MT, Flandrin G, Gallon DAG, Gralnick HR, Sultan C. Proposed revised criteria for the classification of acute myeloid leukemia: a report of the French-American-British Cooperative Group. Ann Intern Med 1995; 103: 626-629.
39. ISCN. Guidelines for cancer cytogenetics, supplement to an international system for human cytogenetic nomenclature. Mitelman F (ed). S Karger: Basel, 1991, p 54.
40. Gu Y, Nakamura T, Alder H, Prasad R, Canaani O, Cimino G, Croce CM, Canaani E. The t(4;11) chromosome translocation of human acute leukemias fuses the ALL 1 gene, related to drosophila trithorax, to the AF4 gene. Cell 1992; 71: 701-708.
41. Campos L, Guyotat D, Archimbaud E, Devaux Y, Treille D, Larese A, Maupas J, Gentilhomme O, Ehrsam A, Fiere D. Surface marker expression in adult acute myeloid leukaemia: correlations with initial characteristics, morphology and response to therapy. Br J Haematol 1989; 72: 161-166.
42. Archimbaud E, Treille-Ritouet D, Guyotat D, Fière D, Viala JJ. Day 4 bone marrow aspirate for prediction of resistance to induction chemotherapy in acute myeloid leukemia. Leukemia Res 1987; 11: 281-283.
43. Castaigne S, Archimbaud E, Fenaux P, Bordessoule D, Tilly H, Simon M, Dupriez B, Auzanneau G, Legros M, Tertian G, Janvier M, Renoux M, Schoenwald M. Place de la double induction dans le traitement des leucémies aigües myéloblastiques de l'adulte: résultats intermédiaires du protocole LAM90. Nouv Rev Fr Hematoi 1994; 36 (Suppl. II): S139-S140.
44. Löwenberg B, Fière D, Zittoun R, Kerkhofs H, Stryckmans P, De Cataldo F, Tura S, Peetermans M, Paulus R, Goudsmit R, Sonnenweld P, Solbu G, Suciu S. Mitoxantrone versus daunorubicin in induction of acute myelogenous leukemia elderly patients and low-dose ara-c vs control as maintenance. An EORTC phase II trial (AML-9). Haematologica 1991; 76 (Suppl. 4): 91.
45. Löwenberg B, Suciu S, Zittoun R, Ossenkoppele G, Boogaerts M, Wijermans P, Vellenga E, Berneman Z, Dekker AW, Sonneveld P, Stryckmans P, Solbu G, Dardenne M, de Witte T, Archimbaud E. GM-CSF during as well as after induction chemotherapy (CT) in elderly patients with acute myeloid leukemia (AML). The EORTC-HOVON phase III trial (AML11). Blood 1995; 86 (Suppl. 1): 433a.
46. Archimbaud E, Jehn U, De Cataldo F, Martin C, Thomas X. Idarubicin or mitoxantrone, VP-16 and cytarabine for induction/ consolidation therapy followed by autologous stem cell transplantation in elderly patients with acute myeloid leukemia (AML): a feasibility study. In: Hiddeman W (ed). Acute Leukemia VI. Prognostic Factors and Treatment Strategies. Springer Verlag: Berlin, 1996, pp 210-212.
47. Weh HJ, Kuse R, Hoffmann R, Seeger D, Suciu S, Kabisch H, Ritter J, Hossfeld DK. Prognostic significance of chromosome analysis in de novo acute myeloid leukemia (AML). Blut 1988; 56: 19-26.
48. Schiffer CA, Lee EJ, Tomiyasu T, Wiernik PH, Testa JR. Prognostic impact of cytogenetic abnormalities in patients with de novo acute nonlymphocytic leukemia. Blood 1989; 73: 263-270.
49. Poirel H, Rack K, Delabesse E, Radford-Weiss I, Troussard X, Debert C, Leboeuf D, Bastard C, Picard F, Veil-Buzyn A, Flandrin G, Bernard O, Macintyre E. Incidence and characterization of MLL gene (11q23) rearrangements in acute myeloid leukemia M1 and M5, Blood 1996; 87: 2496-2505.
50. Caligiuri M, Shichman SA, Strout MP, Mrozek K, Baer MR, Frankel SR, Barcos M, Herzig GP, Croce CM, Bloomfield CD. Molecular rearrangement of the ALL-1 gene in acute myeloid leukemia without cytogenetic evidence of 11q23 chromosomal translocations. Cancer Res 1994; 54: 370-373.
51. Martinez-Climent JA, Thirman MJ, Espinosa II R, Le Beau MM, Rowley JD. Detection of 11q23/MLL. rearrangements in infant leukemias with fluorescence in situ hybridization and molecular analysis. Leukemia 1995; 9: 1299-1304.
52. Schichman SA, Caligiuri MA, Gu Y, Strout MP, Canaani E, Bloom-field CD, Croce CM. ALL-1 partial duplication in acute leukemia? Proc Nati Acad Sci USA 1994; 91: 6236-6239.
53. Raimondi SC, Frestedt JL, Pui CH, Downing JR, Head DR, Kersey JH, Behm FG. Acute lymphoblastic leukemias with deletion of 11 q23 or a novel inversion (11)(p13q23) lack MLL gene rearrangements and have favorable clinical features. Blood 1995; 86: 1881-1886.